HIGHLIGHTS
- who: Anan Manomaipiboon from the Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Dusit, Bangkok, Thailand have published the article: Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial, in the Journal: (JOURNAL) of 15/Dec/2021
- what: The authors aimed to compare the negativity of reverse transcription polymerase chain reaction (RT-PCR) result at days 7 and 14 of enrolment as the primary outcome. This study was approved by the Vajira Institutional Review Board no. 171/64 and was conducted in compliance . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.